DIVI'S LABORATORIES LTD.

  • NSE : DIVISLAB
  • BSE : 532488
  • ISIN CODE : INE361B01024
  • Industry : Pharmaceuticals & Drugs
  • House : Divis Labs

BSE

6946.75 14.95 (0.22 %)

Prev Close ( ) 6931.80

Open Price ( ) 6944.95

BID Price (QTY) 6940.65 (4)

Offer Price (QTY) 6947.80 (9)

Volume 2625

Today's Low / High ( )

6944.95
7004.40

52 WK Low / High ( )

4396.60
7077.70

NSE

6944.00 6.00 (0.09 %)

Prev Close ( ) 6938.00

Open Price ( ) 6930.00

BID Price (QTY) 6942.50 (30)

Offer Price (QTY) 6944.00 (9)

Volume 121957

Today's Low / High ( )

6930.00
7009.50

52 WK Low / High ( )

4395.30
7071.50

Stock Summary

Trade Value ( in Lacs) 182.35
Dividend Yield(%) 0.43
TTM EPS () 83.21
P/E Ratio 83.60
Book Value () 561.09
Face Value () 2
MCap ( in Mn) 1846665.81
Price/Earning (TTM) 70.75
Price/Sales (TTM) 20.08
Price/Book (MRQ) 12.40
PAT Margin (%) 20.44
ROCE (%) 16.31

Peer Group

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit 0.00 15760.00
Gross Profit 0.00 21320.00
Operating Profit 0.00 25110.00
Net Sales 0.00 76650.00

Shareholding Pattern

Promoters 0%
Non-Institution 0%
Fi / Banks / Insurance 0%
Mutual Funds / UTI 0%
Government 0%
FII 0%
Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office
Address

1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone

040 66966300 / 400

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

Event Calendar

Rolling Forward P/E (EOD)

About Divi's Laboratories Ltd.

Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world. The company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.